Nafion-212 Membrane Solvated by Ethylene and Propylene Carbonates as Electrolyte for Lithium Metal Batteries

The use of cation-exchange membranes as electrolytes for lithium metal batteries can prevent the formation of lithium dendrites during extended cycling and guarantee safe battery operation. In our study, the Nafion-212 membrane in lithium form solvated by a mixture of ethylene carbonate and propylene carbonate (EC-PC) was used as an electrolyte in a lithium metal battery with the LiFePO4 cathode. The Nafion-212-EC-PC electrolyte is electrochemically stable up to 6 V, indicating its suitability for high-energy density batteries. It has an ionic conductivity of 1.9 × 10-4 S/cm at 25 °C and a high lithium transference number. The symmetric Li|Nafion-212-EC-PC|Li cell shows a very low overvoltage of ~0.3 V at a current density of ±0.1 mA/cm2. At 25 °C, the LiFePO4|Nafion-212-EC-PC|Li battery exhibits a capacity of 141, 136, 125, and 100 mAh/g at 0.1, 0.2, 0.5, and 1C rates, respectively. It maintains a capacity of 120 mAh/g at 0 °C and 0.1C with stable performance for 50 charge/discharge cycles. The mechanism of conductivity and capacity retention at low temperatures is discussed.

Development of Hydrogen-Oxygen Fuel Cells Based on Anion-Exchange Electrolytes and Catalysts with Reduced Platinum Content

Studies have been carried out to optimize the composition, formation technique and test conditions of membrane electrode assemblies (MEA) of hydrogen-oxygen anion-exchange membranes fuel cells (AEMFC), based on Fumatech anion-exchange membranes. A non-platinum catalytic system based on nitrogen-doped CNT (CNT_N) was used in the cathode. PtMo/CNT_N catalysts with a reduced content of platinum (10-12 wt.% Pt) were compared with 10 and 60 wt.% Pt/CNT_N at the anode. According to the results of studies under model conditions, it was found that the PtMo/CNT_N catalyst is significantly superior to the 10 and 60 wt.% Pt/CNT_N catalyst in terms of activity in the hydrogen oxidation reaction based on the mass of platinum. The addition of the Fumion ionomer results in minor changes in the electrochemically active surface area and activity in the hydrogen oxidation reaction for each of the catalysts. In this case, the introduction of ionomer-Fumion leads to a partial blocking of the outer surface and the micropore surface, which is most pronounced in the case of the 60Pt/CNT_N catalyst. This effect can cause a decrease in the characteristics of MEA AEMFC upon passing from 10PtMo/CNT_N to 60Pt/CNT_N in the anode active layer. The maximum power density of the optimized MEA based on 10PtMo/CNT_N was 62 mW cm^-2, which exceeds the literature data obtained under similar test conditions for MEA based on platinum cathode and anode catalysts and Fumatech membranes (41 mW cm^-2). A new result of this work is the study of the effect of the ionomer (Fumion) on the characteristics of catalysts. It is shown that the synthesized 10PtMo/CNT_N catalyst retains high activity in the presence of an ionomer under model conditions and in the MEA based on it.

Perfluorosulfonic Acid Membranes Modified with Polyaniline and Hydrothermally Treated for Potentiometric Sensor Arrays for the Analysis of Combination Drugs

A novel potentiometric multisensory system for the analysis of sulfamethoxazole and trimethoprim combination drugs was developed. The potentiometric sensors (Donnan potential (DP) was used as an analytical signal) with an inner reference solution were based on perfluorosulfonic acid (PFSA) membranes modified with polyaniline (PANI) by in situ oxidative polymerization. The order of the membrane treatment with precursor solutions and their concentrations was varied. Additionally, the PFSA/PANI composite membranes were hydrothermally treated at 120 °C. The influence of the preparation conditions and the composition of membranes on their sorption and transport properties was studied. We estimated the factors affecting the sensitivity of DP-sensors based on the PFSA/PANI composite membranes to ions of sulfamethoxazole and trimethoprim simultaneously presented in solutions. A developed multisensory system provided a simultaneous determination of two analytes in aqueous solutions without preliminary separation, derivatization, or probe treatment. The re-estimation of the calibration characteristics of the multisensory system did not show a statistically significant difference after a year of its use. The limits of detection of sulfamethoxazole and trimethoprim were 1.4 × 10^-6 and 8.5 × 10^-8 M, while the relative errors of their determination in the combination drug were 4 and 5% (at 5 and 6% relative standard deviation), respectively.

Improvement of Selectivity of RALEX-CM Membranes via Modification by Ceria with a Functionalized Surface

Ion exchange membranes are widely used for water treatment and ion separation by electrodialysis. One of the ways to increase the efficiency of industrial membranes is their modification with various dopants. To improve the membrane permselectivity, a simple strategy of the membrane surface modification was proposed. Heterogeneous RALEX-CM membranes were surface-modified by ceria with a phosphate-functionalized surface. Despite a decrease in ionic conductivity of the prepared composite membranes, their cation transport numbers slightly increase. Moreover, the modified membranes show a threefold increase in Ca²⁺/Na⁺ permselectivity (from 2.1 to 6.1) at low current densities.

Selectivity of Transport Processes in Ion-Exchange Membranes: Relationship with the Structure and Methods for Its Improvement

Nowadays, ion-exchange membranes have numerous applications in water desalination, electrolysis, chemistry, food, health, energy, environment and other fields. All of these applications require high selectivity of ion transfer, i.e., high membrane permselectivity. The transport properties of ion-exchange membranes are determined by their structure, composition and preparation method. For various applications, the selectivity of transfer processes can be characterized by different parameters, for example, by the transport number of counterions (permselectivity in electrodialysis) or by the ratio of ionic conductivity to the permeability of some gases (crossover in fuel cells). However, in most cases there is a correlation: the higher the flux density of the target component through the membrane, the lower the selectivity of the process. This correlation has two aspects: first, it follows from the membrane material properties, often expressed as the trade-off between membrane permeability and permselectivity; and, second, it is due to the concentration polarization phenomenon, which increases with an increase in the applied driving force. In this review, both aspects are considered. Recent research and progress in the membrane selectivity improvement, mainly including a number of approaches as crosslinking, nanoparticle doping, surface modification, and the use of special synthetic methods (e.g., synthesis of grafted membranes or membranes with a fairly rigid three-dimensional matrix) are summarized. These approaches are promising for the ion-exchange membranes synthesis for electrodialysis, alternative energy, and the valuable component extraction from natural or waste-water. Perspectives on future development in this research field are also discussed.

Treatment of chronic hepatitis B with lamivudine in renal transplant recipients

Treatment of chronic hepatitis B in renal transplant recipients remains one of the major problems in clinical nephrology. Lamivudine is considered to be a drug of choice for these patients, however, its efficacy in patients with hepatitis B after renal transplantation (RT) has not been completely proven. Twenty-two RT recipients treated with lamivudine were evaluated. The duration of treatment was 15.6+/-1.9 months. Fourteen patients (64%) had normalization of aminotransferase (ALT); in 9 of them (41% of the whole group), serum HBV DNA was eliminated. Serum HBeAg was undetectable in 4 out of 15 (27%) previously positive patients. It has been statistically proven that the efficacy of lamivudine therapy correlates with degree of fibrosis and higher histological activity index values. We could not establish any correlation between the outcome of antiviral therapy and patients' age, sex, conditions of contagion (while on dialysis or after RT), time lapsed after the infection had been detected, duration of post-transplant period, type of immunosuppression, HBeAg positivity or negativity, ALT levels, concomitant HCV infection. The efficacy of antiviral HBV therapy is limited by the duration of lamivudine treatment: in 4 out of 5 patients with virologic response, the viremia condition relapsed several weeks after the medication had been stopped. Two patients continued to sustain their biochemical response and 1 patient had ALT levels elevated to above normal, but the value was almost twice as low as initially reported. Liver biopsy was repeated in 4 RT recipients after the end of antiviral therapy; in 3 of them positive morphologic changes were observed.